0001562180-19-003935.txt : 20190715 0001562180-19-003935.hdr.sgml : 20190715 20190715090221 ACCESSION NUMBER: 0001562180-19-003935 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190711 FILED AS OF DATE: 20190715 DATE AS OF CHANGE: 20190715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHEINBERG DAVID A CENTRAL INDEX KEY: 0001250316 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 19954192 MAIL ADDRESS: STREET 1: 325 CENTRAL PARK W STREET 2: APT 38 CITY: NEW YORK STATE: NY ZIP: 10025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE WORLD TRADE CENTER STREET 2: 47TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: 646-975-2500 MAIL ADDRESS: STREET 1: ONE WORLD TRADE CENTER STREET 2: 47TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-07-11 false 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001250316 SCHEINBERG DAVID A ONE WORLD TRADE CENTER 47TH FLOOR, SUITE J NEW YORK NY 10007 true false false false Non-Qualified Stock Option (Right to Buy) 5.74 2019-07-11 4 A false 25000.00 0.00 A 2029-07-11 Common Stock 25000.00 25000.00 D The stock options become exercisable in 12 monthly installments, commencing one month from the grant date. /s/ David A. Scheinberg 2019-07-15